Federal University of Santa Catarina   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Florianopolis Brazil (1960)

Organization Overview

First Clinical Trial
2009
NCT01676987
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Federal University of Santa Catarina | Instituto de Cardiologia de Santa Catarina | NUPAIVA Asthma Research Center, UFSC- Brazil | Universidade Federal de Santa Catarina | Universidade Federal de Santa Catarina - UFSC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Cholecystolithiasis (Phase 4)

Cholelithiasis (Phase 4)

Gallstones (Phase 4)

Infarction (Phase 2)

Myocardial Infarction (Phase 2)

Neuralgia (Phase 4)

ST Elevation Myocardial Infarction (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 15